Tanshinone IIA enhances the therapeutic efficacy of mesenchymal stem cells derived exosomes in myocardial ischemia/reperfusion injury via up-regulating miR-223-5p

被引:44
作者
Li, Sheng [1 ,2 ]
Yang, Ke [1 ,2 ]
Cao, Weilong [1 ,2 ]
Guo, Rui [1 ,2 ]
Liu, Zhihao [1 ,2 ]
Zhang, Jing [1 ,2 ]
Fan, Aodi [1 ,2 ]
Huang, Yuting [4 ]
Ma, Chuanrui [1 ]
Li, Lan [1 ,2 ]
Fan, Guanwei [1 ,2 ,3 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Natl Clin Res Ctr Chinese Med Acupuncture & Moxibu, State Key Lab Component based Chinese Med, Teaching Hosp 1, Tianjin, Peoples R China
[2] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Key Lab Pharmacol Tradit Chinese Med Formulae, Minist Educ, Tianjin, Peoples R China
[3] Huanggang Normal Univ, Hubei Key Lab Econ Forest Germplasm Improvement &, Huanggang, Peoples R China
[4] Gannan Med Univ, Affiliated Hosp 1, Key Lab Prevent & Treatment Cardiovasc & Cerebrova, Minist Educ, Ganzhou 341000, Peoples R China
关键词
Exosomes; Tanshinone IIA; miR-223-5p; Myocardial ischemia reperfusion; Mesenchymal stem cell; ISCHEMIA REPERFUSION INJURY; DISEASE JACC MACROPHAGE; ANGIOGENESIS; SECRETION; PROTECTS; IMPROVE;
D O I
10.1016/j.jconrel.2023.04.014
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Myocardial ischemia-reperfusion injury (MI/RI) is a serious obstacle for patients with coronary heart disease (CHD) to benefit from post-ischemic reflow. The low immunogenicity and low carcinogenicity of mesenchymal stem cells (MSCs)-derived exosomes (exo) offer advantage in treating myocardial injuries. Tanshinone IIA (TSA) is an effective drug for MI/RI treatment. However, the underlying mechanism and targets remain obscure. In this study, we systematically investigated the therapeutic effect and its mechanism of TSA-pretreated MSC-derived exosomes (TSA-MSCexo) in ameliorating MI/RI in rats. Expectedly, the MI/RI was significantly relieved by TSA-MSCexo compared with MSCexo. Moreover, the overexpression of CCR2 in rats' heart was used to determine CCR2 had a regulatory effect on monocyte infiltration and angiogenesis after MI/RI. MiRNA microarray analysis of MSCexo and TSA-MSCexo revealed miR-223-5p an effective candidate mediator for TSA-MSCexo to exert its car-dioprotective function and CCR2 as the downstream target. In summary, our findings indicated that miR-223-5p packaged in TSA-MSCexo inhibited CCR2 activation to reduce monocyte infiltration and enhanced angiogenesis to alleviate MI/RI. Thus, the development of cell free therapies for exosomes derived from the combination TSA and MSC provides an effective strategy for the clinical therapies of ischemic cardiomyopathy.
引用
收藏
页码:13 / 26
页数:14
相关论文
共 45 条
[1]   Tissue Resident CCR2-and CCR2+Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury [J].
Bajpai, Geetika ;
Bredemeyer, Andrea ;
Li, Wenjun ;
Zaitsev, Konstantin ;
Koenig, Andrew L. ;
Lokshina, Inessa ;
Mohan, Jayaram ;
Ivey, Brooke ;
Hsiao, His-Min ;
Weinheimer, Carla ;
Kovacs, Attila ;
Epelman, Slava ;
Artyomov, Maxim ;
Kreisel, Daniel ;
Lavine, Kory J. .
CIRCULATION RESEARCH, 2019, 124 (02) :263-278
[2]   Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A [J].
Barile, Lucio ;
Cervio, Elisabetta ;
Lionetti, Vincenzo ;
Milano, Giuseppina ;
Ciullo, Alessandra ;
Biemmi, Vanessa ;
Bolis, Sara ;
Altomare, Claudia ;
Matteucci, Marco ;
Di Silvestre, Dario ;
Brambilla, Francesca ;
Fertig, Tudor Emanuel ;
Torre, Tiziano ;
Demertzis, Stefanos ;
Mauri, Pierluigi ;
Moccetti, Tiziano ;
Vassalli, Giuseppe .
CARDIOVASCULAR RESEARCH, 2018, 114 (07) :992-1005
[3]  
Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI [10.1161/CIR.0000000000000746, 10.1161/CIR.0000000000000659]
[4]   MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome [J].
Chen, Liangqi ;
Hou, Xinyu ;
Zhang, Maomao ;
Zheng, Yang ;
Zheng, Xianghui ;
Yang, Qingyuan ;
Li, Jing ;
Gu, Nan ;
Zhang, Min ;
Sun, Yong ;
Wu, Jian ;
Yu, Bo .
MOLECULAR IMMUNOLOGY, 2020, 117 :73-83
[5]   Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning [J].
de Couto, Geoffrey ;
Gallet, Romain ;
Cambier, Linda ;
Jaghatspanyan, Ervin ;
Makkar, Nupur ;
Dawkins, James Frederick ;
Berman, Benjamin P. ;
Marban, Eduardo .
CIRCULATION, 2017, 136 (02) :200-+
[6]   Monocyte and Macrophage Dynamics in the Cardiovascular System JACC Macrophage in CVD Series (Part 3) [J].
Fayad, Zahi A. ;
Swirski, Filip K. ;
Calcagno, Claudia ;
Robbins, Clinton S. ;
Mulder, Willem ;
Kovacic, Jason C. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (18) :2198-2212
[7]   The mechanistic basis of infarct healing [J].
Frangogiannis, Nikolaos G. .
ANTIOXIDANTS & REDOX SIGNALING, 2006, 8 (11-12) :1907-1939
[8]   MACROPHAGES AND CARDIOVASCULAR HEALTH [J].
Frodermann, Vanessa ;
Nahrendorf, Matthias .
PHYSIOLOGICAL REVIEWS, 2018, 98 (04) :2523-2569
[9]   Myocardial reperfusion injury: looking beyond primary PCI [J].
Froehlich, Georg M. ;
Meier, Pascal ;
White, Steven K. ;
Yellon, Derek M. ;
Hausenloy, Derek J. .
EUROPEAN HEART JOURNAL, 2013, 34 (23) :1714-+
[10]   MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization [J].
Gou, Weihui ;
Zhang, Zhen ;
Yang, Chunfeng ;
Li, Yumei .
EXPERIMENTAL CELL RESEARCH, 2018, 366 (01) :41-48